- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 243/34 - Preparation including building-up the benzodiazepine skeleton from compounds already containing hetero rings containing a quinazoline or hydrogenated quinazoline ring system
Patent holdings for IPC class C07D 243/34
Total number of patents in this class: 7
10-year publication summary
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Signum Dermalogix, Inc. | 13 |
3 |
| Bayer Pharma AG | 1002 |
1 |
| Amgen Inc. | 4486 |
1 |
| Ohio State Innovation Foundation | 2442 |
1 |
| Vigil Neuroscience, Inc. | 56 |
1 |
| Other owners | 0 |